Finance

Lists
Why is 542934 down 4,31%?
Dive Deeper
542934:BOM
Chandra Bhagat Pharma Ltd
40,00 INR
-4,31%
(-1,80) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 542934...
Open
40,00 INR
High
40,00 INR
Low
40,00 INR
Mkt. cap
301,80 მლნ.
Avg. vol.
3,77 ათ.
Volume
2,00 ათ.
P/E ratio
9,91
52-wk high
52,99 INR
52-wk low
29,70 INR
EPS
4,04 INR
No. of employees
45
Open
40,00 INR
High
40,00 INR
Low
40,00 INR
Mkt. cap
301,80 მლნ.
Avg. vol.
3,77 ათ.
Volume
2,00 ათ.
P/E ratio
9,91
52-wk high
52,99 INR
52-wk low
29,70 INR
EPS
4,04 INR
No. of employees
45
News stories
From web sources and news partners
About Chandra Bhagat Pharma Ltd
CEO-
Employees45
Founded1944
Headquarters-
SectorHealth care provider
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
127,73 მლნ.
127,73 მლნ.
456,17 მლნ.
456,17 მლნ.
Cost of goods sold
89,68 მლნ.
89,68 მლნ.
378,79 მლნ.
378,79 მლნ.
Cost of revenue
89,68 მლნ.
89,68 მლნ.
378,79 მლნ.
378,79 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,54 მლნ.
5,54 მლნ.
12,31 მლნ.
12,31 მლნ.
Operating expense
31,07 მლნ.
31,07 მლნ.
65,81 მლნ.
65,81 მლნ.
Total operating expenses
120,76 მლნ.
120,76 მლნ.
444,60 მლნ.
444,60 მლნ.
Operating income
6,97 მლნ.
6,97 მლნ.
11,57 მლნ.
11,57 მლნ.
Other non operating income
-
-
-626,00 ათ.
-626,00 ათ.
EBT including unusual items
2,93 მლნ.
2,93 მლნ.
18,36 მლნ.
18,36 მლნ.
EBT excluding unusual items
2,93 მლნ.
2,93 მლნ.
18,36 მლნ.
18,36 მლნ.
Income tax expense
685,50 ათ.
685,50 ათ.
5,37 მლნ.
5,37 მლნ.
Effective tax rate
23,39%
23,39%
29,26%
29,26%
Other operating expenses
22,48 მლნ.
22,48 მლნ.
51,06 მლნ.
51,06 მლნ.
Net income
2,25 მლნ.
2,25 მლნ.
12,98 მლნ.
12,98 მლნ.
Net profit margin
1,76%
1,76%
2,85%
2,85%
Earnings per share
-
-
-
-
Interest and investment income
-
-
181,50 ათ.
181,50 ათ.
Interest expense
-4,04 მლნ.
-4,04 მლნ.
-5,35 მლნ.
-5,35 მლნ.
Net interest expenses
-4,04 მლნ.
-4,04 მლნ.
-5,16 მლნ.
-5,16 მლნ.
Depreciation and amortization charges
3,06 მლნ.
3,06 მლნ.
2,44 მლნ.
2,44 მლნ.
EBITDA
10,03 მლნ.
10,03 მლნ.
13,66 მლნ.
13,66 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები